Arima S - Search Results

1

Endothelium-derived nitric oxide modulates vascular action of aldosterone in renal arteriole.

Arima S, Kohagura K, Xu HL, Sugawara A, Uruno A, Satoh F, Takeuchi K, Ito S. Arima S, et al. Hypertension. 2004 Feb;43(2):352-7. doi: 10.1161/01.HYP.0000111138.78714.1a. Epub 2003 Dec 22. Hypertension. 2004. PMID: 14691200

2

Biphasic vasodilator action of troglitazone on the renal microcirculation.

Arima S, Kohagura K, Takeuchi K, Taniyama Y, Sugawara A, Ikeda Y, Abe M, Omata K, Ito S. Arima S, et al. J Am Soc Nephrol. 2002 Feb;13(2):342-349. doi: 10.1681/ASN.V132342. J Am Soc Nephrol. 2002. PMID: 11805161

3

Nongenomic vascular action of aldosterone in the glomerular microcirculation.

Arima S, Kohagura K, Xu HL, Sugawara A, Abe T, Satoh F, Takeuchi K, Ito S. Arima S, et al. J Am Soc Nephrol. 2003 Sep;14(9):2255-63. doi: 10.1097/01.asn.0000083982.74108.54. J Am Soc Nephrol. 2003. PMID: 12937301

4

Hepatocyte growth factor stimulates nitric oxide production through endothelial nitric oxide synthase activation by the phosphoinositide 3-kinase/Akt pathway and possibly by mitogen-activated protein kinase kinase in vascular endothelial cells.

Uruno A, Sugawara A, Kanatsuka H, Arima S, Taniyama Y, Kudo M, Takeuchi K, Ito S. Uruno A, et al. Among authors: arima s. Hypertens Res. 2004 Nov;27(11):887-95. doi: 10.1291/hypres.27.887. Hypertens Res. 2004. PMID: 15824471 Free article.

5

20-HETE requires increased vascular tone to constrict rabbit afferent arterioles.

Arima S, Omata K, Ito S, Tsunoda K, Abe K. Arima S, et al. Hypertension. 1996 Mar;27(3 Pt 2):781-5. doi: 10.1161/01.hyp.27.3.781. Hypertension. 1996. PMID: 8613240

6

Endogenous nitric oxide and epoxyeicosatrienoic acids modulate angiotensin II-induced constriction in the rabbit afferent arteriole.

Kohagura K, Endo Y, Ito O, Arima S, Omata K, Ito S. Kohagura K, et al. Among authors: arima s. Acta Physiol Scand. 2000 Jan;168(1):107-12. doi: 10.1046/j.1365-201X.2000.00638.x. Acta Physiol Scand. 2000. PMID: 10691787

7

Involvement of cytochrome P450 metabolites in the vascular action of angiotensin II on the afferent arterioles.

Kohagura K, Arima S, Endo Y, Chiba Y, Ito O, Abe M, Omata K, Ito S. Kohagura K, et al. Among authors: arima s. Hypertens Res. 2001 Sep;24(5):551-7. doi: 10.1291/hypres.24.551. Hypertens Res. 2001. PMID: 11675950 Free article.

8

The mechanisms underlying altered vascular resistance of glomerular afferent and efferent arterioles in diabetic nephropathy.

Arima S, Ito S. Arima S, et al. Nephrol Dial Transplant. 2003 Oct;18(10):1966-9. doi: 10.1093/ndt/gfg263. Nephrol Dial Transplant. 2003. PMID: 13679465 Review. No abstract available.

9

Role of renal eicosanoids in the control of intraglomerular and systemic blood pressure during development of hypertension.

Arima S, Ito S. Arima S, et al. Contrib Nephrol. 2004;143:65-76. doi: 10.1159/000078712. Contrib Nephrol. 2004. PMID: 15248356 Review. No abstract available.

10

High glucose augments angiotensin II action by inhibiting NO synthesis in in vitro microperfused rabbit afferent arterioles.

Arima S, Ito S, Omata K, Takeuchi K, Abe K. Arima S, et al. Kidney Int. 1995 Sep;48(3):683-9. doi: 10.1038/ki.1995.338. Kidney Int. 1995. PMID: 7474652 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

417 results

Search Page

Filters